BioCorRx (BICX) Enterprise Value Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn |
| 10 | BioCorRx | - | - | 189,355.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.30% |
| Dec 31, 2025 | -31.69% |
| Sep 30, 2025 | 63.01% |
| Jun 30, 2025 | -29.32% |
| Mar 31, 2025 | 6.70% |
| Dec 31, 2024 | -16.60% |
| Sep 30, 2024 | 41.60% |
| Jun 30, 2024 | 42.67% |
| Mar 31, 2024 | 51.54% |
| Dec 31, 2023 | 35.03% |
| Sep 30, 2023 | 35.26% |
| Jun 30, 2023 | 40.74% |
| Mar 31, 2023 | 56.44% |
| Dec 31, 2022 | 58.57% |
| Sep 30, 2022 | 63.01% |
| Jun 30, 2022 | 63.81% |
| Mar 31, 2022 | -1.41% |
| Dec 31, 2021 | 16.69% |
| Sep 30, 2021 | -51.37% |
| Jun 30, 2021 | -12.43% |
| Mar 31, 2021 | -938.90% |
| Dec 31, 2020 | -296.59% |
| Sep 30, 2020 | -54.69% |
| Jun 30, 2020 | -22.67% |
| Mar 31, 2020 | -33.36% |
| Dec 31, 2019 | -167.51% |
| Sep 30, 2019 | -256.95% |
| Jun 30, 2019 | -60.82% |
| Mar 31, 2019 | -37.73% |
| Dec 31, 2018 | -16.98% |
| Sep 30, 2018 | -206.15% |
| Jun 30, 2018 | -65.26% |
| Mar 31, 2018 | 56.12% |
| Dec 31, 2017 | 40.23% |
| Sep 30, 2017 | -228.22% |
| Jun 30, 2017 | -38.09% |
| Mar 31, 2017 | -135.50% |
| Dec 31, 2016 | -9.48% |
| Dec 31, 2015 | -232.21% |
| Dec 31, 2014 | -217.67% |
| Dec 31, 2013 | -147.88% |